Therapeutic decisions in the management of arterial hypertension in Poland - Results of the DETENT study;Decyzje terapeutyczne w leczeniu nadciśnienia tȩtniczego w polsce - Wyniki badania DETENT

Nadcisnienie Tetnicze

Volumn 12, Issue 6, 2008, Pages 408-418

  Szczepaniak Chicheł, Ludwina ^a   Tykarski, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Arterial hypertension; Epidemiological survey; Pharmacotherapy; Poland

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGIST; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MONOTHERAPY; PHYSICIAN; POLAND; PRIMARY MEDICAL CARE;

EID: 58149489615     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tykarski A., Posadzy-Malaczyh́ska A., Wyrzykowski B. i wsp. Wieloośrodkowe ogólnopolskie badanie stanu zdrowia ludności - projekt WOBASZ. Rozpowszechnienie nadciśnienia tȩtniczego oraz skuteczność jego leczenia u doroslych mieszkańców naszego kraju. Wyniki programu WOBASZ. Kardiol. Pol. 2005; 63 (supl. 4): 614-619.
2. Zdrojewski T., Bandosz P., Szpakowski P. i wsp. Ocena wybranych problemów dotycza̧cych rozpowszechnienia i terapii nadciśnienia tétniczego w Polsce na podstawie badania NATPOL PLUS. W: Wiȩcek A., Kokot F. (red.). Postȩpy w nefrologii i nadcişnieniu tȩtniczym. Tom II. Medycyna Praktyczna, Kraków 2002: 11-15.
3. Wolf-Maier K., Cooper R., Kramer H. i wsp. Hypertension treatment and control in five European countries, Canada and the United States. Hypertension 2004; 43: 10-17.
4. Kearney P.M., Whelton M., Reynolds K. i wsp. Worldwide prevalence of hypertension: a systematic review. J. Hypertens. 2004; 22:11-19.
5. Burt V.L., Cutler J.A., Higgins M. i wsp. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-69.
6. Okonofua E.C., Simpson K.N., Jesri A. i wsp. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 2006; 47: 345-351.
7. Fine L.J., Cutler J.A. Hypertension and the treating physician - understanding and reducing therapeutic inertia. Hypertension 2006; 47: 319-320.
8. The Task Force tor the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines tor the Management of Arterial Hypertension. J. Hypertens. 2007; 25:1105-1187.
9. Rywik S.L., Davis C.E., Paja̧k A. i wsp. Poland and US collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment and control of hypertension in the Pol-Monica Project and the US Atherosclerosis Risk in Communities Study. Ann. Epidemiol. 1998; 8:3-13.
10. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
11. Ambrosioni E., Leonetti G., Pessina A. i wsp. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. J. Hypertens. 2000; 18: 1691-1699.
12. Colhoun H.M., Dong W., Poulter N.R. Blood pressure screening, management and control in England: results from the heart survey for England 1994. J. Hypertens. 1998; 16:747-752.
13. Primatesta P., Brookes M., Poulter N.R. Improved hypertension management and control. Results from the Health Survey for England 1988. Hypertension 2001; 38: 827-832.
14. BHS Guidelines tor management ot hypertension in adults in primary care. 12 June 2006. www.bhsoc.org.uk18
15. NICE clinical guideline 34. www.nice.org.uk
16. Hansson L., Zanchetti A., Carruther S.G. i wsp. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
17. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998; 317:703-713.
18. Chobanian A.V., Bakris G.L., Black H.R. i wsp. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42 (6): 1206-1252.
19. Banegas J., Segura J., Ruilope L.M. i wsp. Blood pressurecontrol and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004; 43: 1338-1344